NCT03007979: Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer |
|
|
| Completed | 2 | 55 | US | Palbociclib, Ibrance, Letrozole, Femara, Fulvestrant, Faslodex, Optional research biopsy, Goserelin, Zoladex, Research blood draw, Circulating tumor cell blood draw, Tumor biopsy (optional) | Washington University School of Medicine, Pfizer | Breast Cancer, Breast Carcinoma, Cancer of Breast, Malignant Tumor of Breast | 03/20 | 03/23 | | |
